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Introduction  
Hydrogels are polymeric networks with three-dimensional configuration capable of imbibing 
high amounts of water or biological fluids. Hydrogels work well in the body because they 
mimic the natural structure of the body’s cellular makeup. As a result of this, the area of 
hydrogel research has expanded dramatically in the recent past, primarily because hydrogels 
perform well for biomedical applications [1]. Recent advances in the use of hydrogels have 
led to the potential to design artificial organs, deliver drugs to specific sites in the body in a 
controlled fashion and fabricate the extended wear contact lenses [2-4].  
A truly amazing class of hydrogels that has found potential use for a wide variety of 
applications is the class of “smart” or “intelligent” hydrogels.  The uniqueness of this class is 
due to the unusual volume changes that these polymers exhibit under the application of very 
specific stimuli. Smart hydrogels exhibit significant volume changes in response to stimuli 
such as changes in pH, temperature, electric field, ionic strength and light etc. Research 
efforts on the design of smart hydrogels for drug delivery application have increased 
significantly over the past few years [5-6]; the idea behind this approach is that smart 
hydrogels will both expand and contract, forming a hydrogel “switch” that releases drug or 
protein in a controlled fashion. The developments in this area of research have been 
extensively reviewed periodically by various scientists [2-6]. 
Variations in pH are known to occur at several body sites, such as the gastrointestinal tract, 
vagina and blood vessels, and these can provide a suitable base for pH-responsive drug 
release. Most commonly studied ionic polymers for pH-responsive behaviour include 
chitosan, poly (acrylamide) (PAAm), poly (acrylic acid) (PAA), poly (methacrylic acid) 
(PMAA), poly (diethylaminoethyl methacrylate) (PDEAEMA) and poly (dimethylaminoethyl 
methacrylate) (PDMAEMA) [7-8]. 
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Chitosan, α (14) 2-amino-2-deoxy-β-D glucan, is a polycationic bioplomer generally 
obtained by alkaline deacetylation of chitin, which is the main component of the exoskeleton 
of crustaceans such as shrimps [9]. Chitosan has received a great deal of attention in the 
fabrication of pH-responsive hydrogels due to its biocompatibility, low toxicity, degradability 
by human enzymes, membrane permeation enhancing effect, mucoadhesive, antimicrobial as 
well as wound healing properties [10]. Chitosan hydrogels have been greatly employed for 
targeted drug delivery applications and have also been utilized for gene and protein delivery 
purposes [11]. The interest in chitosan as intestinal drug delivery carriers arises from the fact 
that it is degraded by the microflora of the colon and is not digested in the upper 
gastrointestinal tract. Moreover, it has the special feature of adhering to mucosal surfaces 
which makes it highly useful for mucosal drug delivery applications.  Chitosan hydrogels, 
however, suffer from certain limitations such as poor mechanical strength, high porosity and 
tendency to absorb moisture [12].  The high porous nature of chitosan hydrogels lead to 
extensive swelling which eventually leads to faster dissolution of the hydrogel before the 
drug has even been delivered. Thus the applicability of pure chitosan hydrogels in drug 
delivery is hindered. A number of strategies have been developed in this context to alleviate 
these problems. One of the most common methods is to incorporate chitosan into another 
polymeric network by the formation of an interpenetrating network (IPN). It has been 
conjugated with other polymers such as poly (vinyl alcohol) (PVA), poly (ethylene glycol) 
(PEG), poly (N-isopropylacrylamide) (PNIPAAm) or PAA. Such composite hydrogels 
possess improved mechanical properties over individual polymers. PVA is widely used in the 
fields of pharmaceutics. It is cheap, bio-compatible, non-toxic and a water soluble polymer. 
Because of the ease of film formation, long-term temperature and pH stability, it is widely 
considered in the class of biomaterials, hydrogels in particular. PVA is commonly used in 
contact lenses, artificial muscles and burn wound dressing material among other biomedical 
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applications [13].  Block copolymers of chitosan and PVA have emerged as one of the most 
promising biodegradable materials due to their highly controllable chemical and physical 
properties [14].  
In the past few decades, pharmaceutical formulations that target specific areas and control the 
rate and period of drug delivery (i.e. timed-release medications) have gained much impulse. 
Conventional drug dosage forms which include pills, tablets, capsules, injections, ointments, 
creams etc. release the drug instantaneously in a bolus form; which calls for frequent dosing 
and increase patient non-compliances. Controlled release of drugs reduces the dosing 
frequency, enhances activity of duration of short half-life drugs, eliminates side-effects and 
drug wastage, optimizes therapy and improves patient compliances [15].    
Cyclodextrins are of special interest in this context given their hydrophilic exterior, which is 
useful for maintaining the bulk hydrophilicity and swelling state of the hydrogel, and their 
hydrophobic interior, which can facilitate the entrapment and controlled release of variety of 
hydrophobic drugs. Cyclodextrins have the potential to reduce the release rate of drug from 
hydrogels even without any covalent linking to the matrixes, for they diffuse in the gel much 
slower than small molecule drugs probably due to their higher excluded volumes, low water-
solubility, and the hydrogen bonding [16]. Efforts are still being made to incorporate 
cyclodextrins into various polymer matrices in order to explore and modify current drug 
release systems. Incorporation of cyclodextrin to polymer matrix is often carried out by 
copolymerization of functionalized cyclodextrin with the polymer of interest. 
Copolymerisation of cyclodextrins with other polymers involves extensive synthesis work 
and most often needs the surface modification of simple cyclodextrins. In order to avoid the 
important drawbacks of the chemical modification of cyclodextrins, a simple and easy 
strategy for incorporating cyclodextrin to hydrogel matrix is to load drug-cyclodextrin 
complexes directly into the hydrogel after or during the gel cross-linking.  
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Objective  
To synthesize pH-responsive chitosan-PVA interpenetrating network hydrogels for controlled 
delivery of drug to the intestine.  
Work Plan: 
I. Synthesis of pH-responsive chitosan-PVA interpenetrating network hydrogels 
using glutaraldehyde as crosslinker. Characterisation of these hydrogels by FTIR, 
XRD and SEM techniques. Evaluation of pH-responsive swelling characteristics 
of the hydrogels in phosphate buffer solutions. Antibacterial assay of the 
synthesized hydrogels using E. coli (gram negative) by the disc diffusion method. 
II. Investigation of drug inclusion in cyclodextrin. Preparation of solid inclusion 
complexes of drug in β-cyclodextrin (CD). Characterization of the inclusion 
complexes by various spectroscopic methods such as FTIR, XRD, DSC, SEM, 
NMR, UV-Vis spectrophotometry and Fluorescence spectroscopy.  
III. Study of drug releasing properties of the hydrogels in vitro by UV-Vis 
spectrophotometry. Preliminary kinetic analyses and determination of probable 
mechanism of drug release from the hydrogels using four basic empirical 
mathematical models; Zero order, Higuchi, Ritger-Peppas and Peppas-Sahlin 
models.  
Work done so far: 
 A detailed literature appraisal is being carried out on chitosan and PVA hydrogels and 
their applications in biomedical and pharmaceutical industries and more importantly 
as drug delivery agents. 
 Hydrogels composed of chitosan and PVA in different feed ratios were synthesized 
using glutaraldehyde as crosslinker. The compositions of the hydrogels are listed in 
Table I. 
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Table I. Compositions of synthesized hydrogels 
 
Sample 
 
CS: PVA 
(wt%) 
CS/PVA 
1 1:0 CS 
2 1:1 HG11 
3 1:3 HG13 
4 1:5 HG15 
 
 The representative FTIR spectra of the hydrogels are shown in Figure 1.    
 
 
 
 
 
 
  Figure 1. FTIR spectra of pure Chitosan, pure PVA and HG15 hydrogel 
As observed from the FTIR spectra, the characteristics peaks of CS and PVA are seen in 
the spectrum of HG15 hydrogel with certain modifications in the absorption frequencies. 
The amide peak at 1510 cm
-1 
which is a characteristic of CS, is present. Moreover, the 
peaks at 893 cm
-1
 and 1155 cm
-1
 due to the pyranose ring and saccharin structure confirm 
the presence of chitosan in the HG15 hydrogel. The broad band at 3400 - 3250 cm
-1
 in is 
due to O-H stretching of PVA. Alkyl group C-H stretching is also observed in the IPN 
sample at 3000 cm
-1
. 
 The X-ray diffraction profiles of the hydrogels are shown in Figure 2. 
Pure chitosan shows a broad and weak diffraction at around 10° and a relatively sharp 
diffraction at 19.5°. PVA shows a sharp peak centred on diffraction angle of 19.64° 
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associated with the crystalline nature of PVA. The diffraction profile of HG15 hydrogel 
exhibits a strong reflection at an angle of around 19°. The diffraction peak has been 
somewhat shifted and broadened in nature, probably due to interpolymer interaction 
between chitosan and PVA.  
 
 
 
 
 
 
     Figure 2. XRD profiles of Chitosan and HG15 hydrogel  
 The morphology of the hydrogels was investigated by Scanning Electron Microscopy 
(SEM). The hydrogels were initially swollen in buffer solutions till equilibrium 
swelling was attained. They were then frozen at −20°C for 6 h and then lyophilized 
for 48 h. SEM was performed on freeze-dried hydrogels to know the bulk morphology 
of the hydrogels. The SEM micrographs are depicted in Figure 3. 
   
                 Figure 3. SEM micrographs of (A) pure chitosan and (B) HG15 hydrogel 
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Pure chitosan exhibits a highly porous matrix while HG15 hydrogel is compact in nature. 
This shows that porosity decreases with addition of PVA in the hydrogel which might be 
due to entanglement between chitosan and PVA chains.   
 The pH-responsive swelling behaviour of HG15 hydrogel was studied at pH 1.2 and 
pH 7.4. The swelling curve is indicated in Figure 4. 
 
 
 
 
 
    
  Figure 4. pH-responsive swelling behaviour of HG15 hydrogel 
 The HG15 hydrogel displayed pH-sensitive swelling with maximum swelling at pH 
 7. 4 than at acidic pH 1.2. Due to protonation of the amino group of chitosan at lower 
 pH, strong electrostatic repulsion occurs between the polymer chains. The flow of 
 counterions takes place to make the overall static potential neutral. Thus there is an 
 increased osmotic pressure inside the matrix which reduces the swellability. At 
 neutral pH, de-protonation of the amino group occurs and thus more water enters the 
 hydrogel.   
Conclusion 
 pH-sensitive IPN hydrogels composed of chitosan and PVA were synthesized using 
glutaraldehyde as crosslinker.  
0 5 10 15 20 25
0
400
800
1200
1600
S
w
e
ll
in
g
 %
Time (h)
 HG15 (7.4)
 HG15 (1.2)
9 
 
 The characterization of the hydrogels suggested the proper blending of the individual 
polymers with each other. 
 The swelling properties of the hydrogels indicated maximum swelling at neutral pH 
and lower swelling at acidic pH. 
 The pH-sensitivity of these hydrogels could be utilized for controlled delivery of drug 
to the intestine. 
Future work 
 Preparation of drug-CD inclusion complex by different methods.   
 Detailed analysis of the inclusion complexes by various spectroscopic methods. 
 Synthesis and characterization of hydrogels containing the drug-CD complexes. 
 Antibacterial activity of the hydrogels. 
 Cytotoxicity evaluation of the hydrogels by MTT colorimetric technique. 
 Drug release from hydrogels in simulated gastric and intestinal fluids. 
 Kinetic analysis of drug release process. 
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